Autoimmune Disease Diagnostics Market – Highlights
Autoimmune disease is a disorder where body’s own immune system starts attacking the healthy cells instead of foreign particles and disease-causing agents. The rising awareness about autoimmune disorders, technological advancement in the healthcare sector and rise in number of cases of autoimmune diseases are the factors driving the growth of the global autoimmune disease diagnostics market. Moreover, strategic collaborations and aggressive strategies by major players are also contributing to the growth of the market. For instance, in May 2018, Myriad Genetics, Inc. has acquired Counsyl, Inc. for USD 375 million, Counsyl is a global leader in genetic testing and personalized medicine segment.
The rising cases of false positive result of autoimmune disorders, scarcity of technicians, and price war between companies are likely to hinder market growth during the forecast period.
Avail Sample Copy for this Report https://www.marketresearchfuture.com/sample_request/6715
Segmentation:
The global autoimmune disease diagnostics market has been segmented on the basis of disease type, test type, and end-user.
The market, by disease type, has been classified as systemic autoimmune disease, and localized autoimmune disease. The systemic autoimmune disease segment has been further classified into psoriasis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus (SLE), and others. Localized autoimmune disease segment has been divided into inflammatory bowel disease, thyroid, type 1 diabetes, and others.
On the basis of test type, the market has been segregated into western blotting, enzyme-linked immunosorbent assay (ELISA), double immune diffusion, dot blot, counter immune-electrophoresis, line blot, immunofluorescence assays (IFA), multiplex immunoassay, agglutination, and others.
The end-user segment has been divided into, has been segmented into hospitals, diagnostics centers, research laboratories, and others
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Autoimmune Disease Diagnostics Market, By Disease Type
6.1 Introduction
6.2 Systemic Autoimmune Disease
6.2.1 Psoriasis
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.2.2 Multiple Sclerosis
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.2.3 Rheumatoid Arthritis
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.2.4 Systemic Lupus Erythematosus (SLE)
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.2.5 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3 Localized Autoimmune Disease
6.3.1 Inflammatory Bowel Disease
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3.2 Thyroid
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3.3 Type 1 Diabetes
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3.4 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
Chapter 7. Global Autoimmune Disease DiagnosticsMarket, By Test Type
7.1 Introduction
7.2 Western Blotting
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.3 Enzyme-Linked Immunosorbent Assay (ELISA)
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.4 Double Immune Diffusion
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.5 Dot Blot
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.6 Counter Immune-Electrophoresis
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.7 Line Blot
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.8 Immunofluorescence Assays (IFA)
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.9 Multiplex Immunoassay
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.10 Agglutination
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.11 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
Chapter 8. Global Autoimmune Disease DiagnosticsMarket, By By End-User
8.1 Introduction
8.2 Hospitals
… continue
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/autoimmune-disease-diagnostics-market-6715
Key Players:
Some of the key players in the global autoimmune disease diagnostics market are Siemens Healthcare Private Limited, bioMérieux SA, Bio-rad Laboratories, Beckman Coulter, Inc., AstraZeneca, EUROIMMUN AG, F. Hoffmann-la Roche, Inova Diagnostics, Inc.,Myriad Genetics, Inc., Thermo Fisher Scientific, Trinity Biotech Plc., and Hemagen Diagnostics, Inc.
Regional Analysis:
The Americas are likely to dominate the global autoimmune disease diagnostics market due to the well-established healthcare sector, adoption of advance technology, and rising prevalence of autoimmune disorders. The European market is expected to be the second-largest autoimmune disease diagnostics market. The growing healthcare industry, presence of major market players in the region, and increasing automation in laboratories are the factors responsible for growth of the autoimmune disease diagnostics market in the region. Asia-Pacific is anticipated to be the fastest-growing autoimmune disease diagnostics market during the forecast period owing to the increase in population, rising prevalence of autoimmune disorders, and initiatives by government and private organizations for development of healthcare sector. The market in the Middle East & Africa is likely to account for the smallest share of the global autoimmune disease diagnostics market.
Inquire for Discount at https://www.marketresearchfuture.com/check-discount/6715
Intended Audience
- Healthcare providers
- Medical device manufacturers
- Research institutes and academic centers
- Contract research organizations (CROs)
- Government associations
- Market research and consulting
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
